Annamaria Ruzzo - Concepedia

Author

Annamaria Ruzzo

University of Urbino

Also Known As

A Ruzzo, A. Ruzzo, A.M. Ruzzo, ANNAMARIA RUZZO, Annamaria RUZZO, Annamaria Ruzzo, Ruzzo, Annamaria

117

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

University of Urbino Università Campus Bio-Medico Ospedali Riuniti Marche Nord Azienda Ospedaliera Universitaria Pisana University of Pisa

About

Annamaria Ruzzo is an author at University of Urbino specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	22	1.5K
2	Cell Biology	6	6	298
3	Public Health	4	4	165
4	Natural Sciences	1	1	26
5	Biology	1	1	26

Annamaria Ruzzo

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer Fotios Loupakis, Annamaria Ruzzo, Chiara Cremolini, British Journal of Cancer	2009	557
PTEN Expression and KRAS Mutations on Primary Tumors and Metastases in the Prediction of Benefit From Cetuximab Plus Irinotecan for Patients With Metastatic Colorectal Cancer Fotios Loupakis, Luca Emanuele Pollina, I. Stasi, Journal of Clinical Oncology	2009	402
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition Gabrielle S. Wong, Jin Zhou, Jie Bin Liu, Nature Medicine Tumor BiologyOncologyEsophageal CancerGastrointestinal OncologyMedicine	2018	268
Pharmacogenetic Profiling in Patients With Advanced Colorectal Cancer Treated With First-Line FOLFOX-4 Chemotherapy Annamaria Ruzzo, Francesco Graziano, Fotios Loupakis, Journal of Clinical Oncology	2007	264
High Concordance of <i>KRAS</i> Status Between Primary Colorectal Tumors and Related Metastatic Sites: Implications for Clinical Practice Daniele Santini, Fotios Loupakis, Bruno Vincenzi, The Oncologist	2008	228
Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer Giuseppe Perrone, Pier Adelchi Ruffini, Vincenzo Catalano, European Journal of Cancer Gastrointestinal OncologyMedicineT-regulatory CellImmunologyPathology	2008	208
Genetic Activation of the <i>MET</i> Pathway and Prognosis of Patients With High-Risk, Radically Resected Gastric Cancer Francesco Graziano, Nadia Galluccio, Paola Lorenzini, Journal of Clinical Oncology	2011	164
Pharmacogenetic Profiling for Cetuximab Plus Irinotecan Therapy in Patients With Refractory Advanced Colorectal Cancer Francesco Graziano, Annamaria Ruzzo, Fotios Loupakis, Journal of Clinical Oncology	2008	137
Pharmacogenetic Profiling and Clinical Outcome of Patients With Advanced Gastric Cancer Treated With Palliative Chemotherapy Annamaria Ruzzo, Francesco Graziano, Kazuyuki Kawakami, Journal of Clinical Oncology	2006	134
Genetic modulation of the Let-7 microRNA binding to KRAS 3′-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab–irinotecan Francesco Graziano, Emanuele Canestrari, Fotios Loupakis, The Pharmacogenomics Journal Kras 3′-Untranslated RegionOncologyEpigenetic RegulationMedicineColorectal Cancer	2010	115

Page 1